Published in JAMA Otolaryngol Head Neck Surg on December 01, 2013
Landscape of genomic alterations in cervical carcinomas. Nature (2013) 2.61
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer. Oral Oncol (2014) 0.94
Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. Int J Radiat Oncol Biol Phys (2014) 0.88
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas. BMC Cancer (2015) 0.86
HPV prophylactic vaccination in males improves the clearance of semen infection. EBioMedicine (2015) 0.86
Detection of oral human papillomavirus in HIV-positive men who have sex with men 3 years after baseline: a follow up cross-sectional study. PLoS One (2014) 0.84
Improving oral human papillomavirus detection using toothbrush sampling in HIV-positive men who have sex with men. J Clin Microbiol (2014) 0.82
HPV and cancer of the oral cavity. Virulence (2015) 0.82
Ultrasensitive detection of oncogenic human papillomavirus in oropharyngeal tissue swabs. J Otolaryngol Head Neck Surg (2017) 0.80
Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003-2012. BMC Infect Dis (2015) 0.79
Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine. Genes Cancer (2016) 0.79
The prevalence of human papillomavirus infections and associated risk factors in men-who-have-sex-with-men in Cape Town, South Africa. BMC Infect Dis (2016) 0.78
Classification of TP53 mutations and HPV predict survival in advanced larynx cancer. Laryngoscope (2016) 0.77
Stability of methylation markers in head and neck squamous cell carcinoma. Head Neck (2015) 0.77
Cigarette use, comorbidities, and prognosis in a prospective head and neck squamous cell carcinoma population. Head Neck (2016) 0.77
Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx. J Clin Oncol (2016) 0.76
Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines. Head Neck (2017) 0.75
Human Papilloma Virus in Oral Cavity Cancer and Relation to Change in Quality of Life Following Treatment-a Pilot Study from Northern India. Indian J Surg Oncol (2016) 0.75
Human Papillomavirus (HPV) virion induced cancer and subfertility, two sides of the same coin. Facts Views Vis Obgyn (2017) 0.75
Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma. Mol Cancer Res (2016) 0.75
Impact of HPV infection on oral squamous cell carcinoma. Oncotarget (2016) 0.75
A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression. J Oral Pathol Med (2015) 0.75
Human papillomavirus infection and biomarkers in sinonasal inverted papillomas: clinical significance and molecular mechanisms. Int Forum Allergy Rhinol (2015) 0.75
Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures. Clin Cancer Res (2016) 0.75
Higher prevalence and gene amplification of HPV16 in oropharynx as compared to oral cavity. J Appl Oral Sci (2016) 0.75
High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res (2016) 0.75
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res (1995) 7.42
Carcinogenicity of human papillomaviruses. Lancet Oncol (2005) 5.84
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46
Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol (2010) 4.39
Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer (2005) 3.79
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol (2008) 3.55
Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol (2006) 2.91
Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol (2004) 2.59
Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci (2006) 2.56
Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol (2010) 2.41
Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol (2002) 2.18
Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res (2010) 2.11
Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer (2001) 1.85
High-risk human papillomavirus in nasopharyngeal carcinoma. Head Neck (2011) 1.79
Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res (2012) 1.76
Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proc Natl Acad Sci U S A (2005) 1.74
Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope (2007) 1.61
Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. Cancer Res (2012) 1.49
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys (2007) 1.31
Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck. Clin Cancer Res (1995) 1.28
HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head Neck (2010) 1.23
Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer (2012) 1.17
Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One (2012) 1.14
Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Cancer Genet Cytogenet (2007) 1.05
Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns. Cancer Res (2009) 1.05
Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope (2010) 1.02
Combined Epstein-Barr virus and human papillomavirus infection in nasopharyngeal carcinoma. Laryngoscope (1998) 1.02
Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope (2012) 1.00
Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects. J Natl Cancer Inst (2013) 0.98
Human papillomaviruses and cancer. Radiother Oncol (2013) 0.97
The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma. Laryngoscope (2002) 0.97
Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene (1999) 0.95
Does HPV type affect outcome in oropharyngeal cancer? J Otolaryngol Head Neck Surg (2013) 0.94
Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands. Anticancer Res (2000) 0.91
High prevalence of p16 genetic alterations in head and neck tumours. Br J Cancer (1999) 0.90
A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers. Cancer Lett (1998) 0.89
Human papillomavirus & WHO type I nasopharyngeal carcinoma. Laryngoscope (2010) 0.82
Genetic alterations in head and neck squamous cell carcinomas. Braz J Med Biol Res (1999) 0.81
Gaseous nitrogen oxides stimulate cell cycle progression by retinoblastoma phosphorylation via activation of cyclins/Cdks [correction]. Toxicol Sci (2003) 0.81
Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma Treatment. JAMA Otolaryngol Head Neck Surg (2016) 1.39
Quality of Abstracts Reporting Randomized Clinical Trials Presented at a Major Oncology Conference. JAMA Oncol (2016) 0.75